A GRIN3A Polymorphism may be Associated with Glucocorticoid-Induced Symptomatic Osteonecrosis in Children with Acute Lymphoblastic Leukemia

References

• Dabbous IA , DboukH , SibaiA-M , BahlawanL. Childhood acute lymphoblastic leukemia managed in tertiary care center in a developing country. Med. Pediatr. Oncol.41(1), 83–84 (2003).
   PubMedGoogle Scholar
• Muwakkit S , Al-AridiC , SamraAet al. Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon. Am. J. Hematol.87(7), 678–683 (2012).
   PubMed Web of Science ®Google Scholar
• Stanulla M , SchrappeM. Treatment of childhood acute lymphoblastic leukemia. Semin. Hematol.46(1), 52–63 (2009).
   PubMed Web of Science ®Google Scholar
• Maamari D , El-KhouryH , SaifiO , MuwakkitSA , ZgheibNK. Implementation of pharmacogenetics to individualize treatment regimens for children with acute lymphoblastic leukemia. Pharmacogenomics Pers. Med.13, 295–317 (2020).
   PubMed Web of Science ®Google Scholar
• Davidsen ML , DalhoffK , SchmiegelowK. Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia. J. Pediatr. Hematol. Oncol.30(11), 831–849 (2008).
   PubMed Web of Science ®Google Scholar
• Caudle KE , KleinTE , HoffmanJMet al. Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. Curr. Drug Metab.15(2), 209–217 (2014).
   PubMed Web of Science ®Google Scholar
• Mont MA , HungerfordDS. Non-traumatic avascular necrosis of the femoral head. J. Bone Joint Surg. Am.77(3), 459–474 (1995).
   PubMed Web of Science ®Google Scholar
• Kunstreich M , KummerS , LawsH-J , BorkhardtA , KuhlenM. Osteonecrosis in children with acute lymphoblastic leukemia. Haematologica101(11), 1295–1305 (2016).
   PubMed Web of Science ®Google Scholar
• Ali N , GoharS , ZakyIet al. Osteonecrosis in children with acute lymphoblastic leukemia: A report from Children’s Cancer Hospital Egypt (CCHE). Pediatr. Blood Cancer66(1), e27440 (2019).
   PubMed Web of Science ®Google Scholar
• Karol SE , MattanoLA , YangWet al. Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia. Blood127(5), 558–564 (2016).
   PubMed Web of Science ®Google Scholar
• Karol SE , YangW , Van DriestSLet al. Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia. Blood126(15), 1770–1776 (2015).
   PubMed Web of Science ®Google Scholar
• Ramsey LB , PoundsS , ChengCet al. Genetics of pleiotropic effects of dexamethasone. Pharmacogenet. Genomics27(8), 294–302 (2017).
   PubMed Web of Science ®Google Scholar
• French D , HamiltonLH , MattanoLAet al. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children’s Oncology Group. Blood111(9), 4496–4499 (2008).
   PubMed Web of Science ®Google Scholar
• Jackson RK , IrvingJAE , VealGJ. Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia. Br. J. Haematol.173(1), 13–24 (2016).
   PubMed Web of Science ®Google Scholar
• Relling MV , YangW , DasSet al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J. Clin. Oncol.22(19), 3930–3936 (2004).
   PubMed Web of Science ®Google Scholar
• Kawedia JD , KasteSC , PeiDet al. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood117(8), 2340–2347 (2011).
   PubMed Web of Science ®Google Scholar
• Karas-Kuželički N , Mencej-BedračS , JazbecJ , MarcJ , Mlinarič-RaščanI. Risk factors for symptomatic osteonecrosis in childhood ALL: a retrospective study of a Slovenian pediatric ALL population between 1970 and 2004. Exp. Ther. Med.12(2), 840–846 (2016).
   PubMed Web of Science ®Google Scholar
• Finkelstein Y , BlonquistTM , VijayanathanVet al. A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia. Pediatr. Blood Cancer64(7), (2017).
   PubMed Web of Science ®Google Scholar
• Zgheib NK , AkikaR , MahfouzRet al. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children’s Cancer Center of Lebanon. Pediatr. Blood Cancer64(1), 146–150 (2017).
   PubMed Web of Science ®Google Scholar
• Zgheib NK , Akra-IsmailM , AridiCet al. Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. Pharmacogenet. Genomics.24(8), 387–396 (2014).
   PubMed Web of Science ®Google Scholar
• Schmiegelow K , AttarbaschiA , BarzilaiSet al. Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus. Lancet Oncol.17(6), e231–e239 (2016).
   PubMed Web of Science ®Google Scholar
• Quddus FF , LeventhalBG , BoyettJM , PullenDJ , CristWM , BorowitzMJ. Glucocorticoid receptors in immunological subtypes of childhood acute lymphocytic leukemia cells: a Pediatric Oncology Group Study. Cancer Res.45(12 Pt. 1), 6482–6486 (1985).
   PubMed Web of Science ®Google Scholar
• Tissing WJE , MeijerinkJPP , den BoerML , PietersR. Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia17(1), 17–25 (2003).
   PubMed Web of Science ®Google Scholar
• Tsai SY , Carlstedt-DukeJ , WeigelNLet al. Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell55(2), 361–369 (1988).
   PubMed Web of Science ®Google Scholar
• Jones JP . Fat embolism and osteonecrosis. Orthop. Clin. North Am.16(4), 595–633 (1985).
   PubMed Web of Science ®Google Scholar
• Nishimura T , MatsumotoT , NishinoM , TomitaK. Histopathologic study of veins in steroid treated rabbits. Clin. Orthop. (334), 37–42 (1997).
   PubMed Web of Science ®Google Scholar
• Solomon L . Idiopathic necrosis of the femoral head: pathogenesis and treatment. Can. J. Surg. J. Can. Chir.24(6), 573–578 (1981).
   PubMed Web of Science ®Google Scholar
• Shigemura T , NakamuraJ , KishidaSet al. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. Rheumatol. Oxf. Engl.50(11), 2023–2028 (2011).
   PubMed Web of Science ®Google Scholar
• Padhye B , Dalla-PozzaL , LittleD , MunnsC. Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL). Cancer Med.5(5), 960–967 (2016).
   PubMed Web of Science ®Google Scholar
• Riccio I , PotaE , MarcarelliMet al. Osteonecrosis as a complication in pediatric patients with acute lymphoblastic leukemia. Pediatr. Medica E Chir. Med. Surg. Pediatr.38(3), 118 (2016).
   PubMedGoogle Scholar
• Mogensen SS , Harila-SaariA , MäkitieOet al. Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia. Pediatr. Blood Cancer65(10), e27300 (2018).
   PubMed Web of Science ®Google Scholar
• Pérez-Otaño I , LarsenRS , WesselingJF. Emerging roles of GluN3-containing NMDA receptors in the CNS. Nat. Rev. Neurosci.17(10), 623–635 (2016).
   PubMed Web of Science ®Google Scholar
• Brakspear KS , MasonDJ. Glutamate signaling in bone. Front. Endocrinol.3, 97 (2012).
   PubMedGoogle Scholar
• Lin Y-J , ChangJ-S , LiuXet al. Association between GRIN3A gene polymorphism in Kawasaki disease and coronary artery aneurysms in Taiwanese children. PloS ONE8(11), e81384 (2013).
   PubMed Web of Science ®Google Scholar